IXYS CORPORATION FINANCIAL INFORMATION Third Fiscal Quarter Ended December 31, 2013

The following is financial information disclosed by IXYS Corporation ("IXYS") during its conference call regarding the third fiscal quarter ended December 31, 2013. The information disclosed in IXYS' press release discussing the third fiscal quarter ended December 31, 2013 is not presented below.

Regional Revenues as a Percentage of Net Revenues

Three Months Nine Months

Dec. 31, 2013 Dec. 31, 2013

North America: 26.4% 27.9% Europe & Middle East: 25.7% 29.8% Asia Pacific and ROW: 47.9% 42.3%

CAPEX

$1.9 million for the December 2013 quarter

Gross Profit

Quarter ended December 31, 2013: 28.9% Quarter ended December 31, 2012: 29.7%

Research, Development and Engineering Expenses as a Percentage of Net Revenues

Quarter ended December 31, 2013: 8.8% Quarter ended December 31, 2012: 10.6%

Selling, General and Administrative Expenses as a Percentage of Net Revenues

Quarter ended December 31, 2013: 11.2% Quarter ended December 31, 2012: 14.3%

Current Ratio

December 31, 2013: 3.7
1

Cash

December 31, 2013: $99.1 million
Increase of $3.9 million from September 2013
Cash generated from operations: about $5.7 million

Accounts Receivables

December 31, 2013: $39.9 million

Days Sales Outstanding

December 31, 2013: 40

Inventory

December 31, 2013: $93.6 million

Inventory Turns

December 31, 2013 2.7
Days of inventory = 133 days

Revenue by Market Segment for the period ended December 31, 2013

3 Months 9 Months

Industrial & Commercial

40%

47%

Communication Infrastructure

14%

16%

Medical Electronics

9%

10%

Consumer

23%

13%

Transportation (Auto/Traction)

4%

4%

Other

10%

10%

Revenue by Product for the period ended December 31, 2013

3 Months 9 Months

Power semiconductors:

59.0%

66.6%

ICs:

34.8%

26.7%

Systems & RF:

6.2%

6.7%

2

Adjusted EBITDA for the quarter ended December 31, 2013

Net income $ 552

Add: Interest expense, net

458

Add: Income tax (benefit) expense

2,665

Add: Depreciation and amortization expenses

6,109

EBITDA

$ 9,784

Add: Share-based compensation

692

Adjusted EBITDA

$ 10,476

Forward-Looking Statements

The foregoing document contains forward-looking statements. Actual results may vary materially from those contained in the forward-looking statements, due to changes in customer delivery schedules and cancellations of orders. Further information on other factors that could affect IXYS is detailed and included in IXYS' Form 10-Q for the fiscal quarter ended September 30, 2013 as filed with the Securities and Exchange Commission. IXYS undertakes no obligation to publicly release the results of any revisions to these forward-looking statements.
3

distributed by